Patent Process · USPTO Negotiation

Patent Prosecution Explained

Patent prosecution is the negotiation between applicant and USPTO that turns a patent application into a granted patent. It lasts months or years, and every word you write on the record shapes the patent’s scope forever.

Key takeaways

→Prosecution is the back-and-forth with the USPTO examiner — it starts at filing and ends at grant, abandonment, or appeal.
→Most applications receive at least one Office Action (rejection) before allowance. Rejections are normal, not fatal.
→Every argument and amendment you make goes on the permanent public record and limits your patent's scope in litigation.
→After a final Office Action you have three paths: RCE (reopen), appeal (PTAB), or abandon.
→Prosecution history estoppel: narrowing amendments to overcome prior art can prevent you from claiming those surrendered embodiments as infringement via the doctrine of equivalents.
→Continuation strategy: file before the parent issues if you want to pursue broader claims — once the parent issues, that opportunity closes.

What is prosecution?

The negotiation, not the application

“Patent prosecution” refers to the process of communicating with the USPTO to obtain a granted patent from a filed application. The word comes from the Latin prosequi — to follow or pursue — and in patent law it means exactly that: the applicant pursues allowance through a structured series of rejections and responses.

Prosecution is distinct from the application itself. The application is the document you file. Prosecution is the multi-year dialogue — Office Actions from the examiner, responses from the applicant — that determines what the patent actually claims when granted.

The entire prosecution record — every OA, every response, every interview summary — becomes the public prosecution history (also called the file wrapper). Courts use this record in litigation to interpret claim scope and determine whether prosecution history estoppel bars certain infringement arguments.

The prosecution lifecycle

Seven stages from filing to grant

Filing

Day 1

Prosecution begins when a non-provisional application is filed. The USPTO assigns an application number, art unit, and examiner. Filing date is critical — it establishes the priority date for novelty purposes in the first-to-file system.

Examination begins

Month 6–18

The examiner conducts a prior art search using USPTO's internal databases, classified patent indexes, and commercial databases. The examiner must search all claims in the application. Average wait for a first action is 16–19 months depending on the art unit.

Non-final Office Action

Month 18–24

The examiner issues a non-final rejection or allowance. Most applications receive at least one rejection. The OA identifies specific prior art references and explains how they read on each rejected claim. You have 3 months (fee-extendable to 6) to respond.

Applicant response

Month 21–30

Your attorney argues the claims are distinguishable from the prior art, amends claims to add limitations that differentiate, or both. This is the core negotiation. Arguments go on record in the prosecution history — they matter for future infringement analysis.

Final Office Action (or allowance)

Month 24–36

After reviewing the response, the examiner either allows the application (prosecution ends successfully) or issues a Final OA. 'Final' here means the examiner considers prosecution complete — but it is not truly final: you have three paths forward (RCE, appeal, after-final amendment).

RCE, appeal, or allowance

Month 30–60+

An RCE reopens prosecution (costs ~$1,320) with the same examiner. An appeal to PTAB puts the case before a panel of judges (takes 2–4 years but costs less if you are right). Many applications allow after amended claims satisfy the examiner in a follow-up interview.

Notice of Allowance and issue fee

Variable

When all claims are in condition for allowance, the USPTO issues a Notice of Allowance (NOA). You have 3 months to pay the issue fee ($1,200–$2,400). After payment, the patent typically issues within 4–6 weeks.

Office Actions

Understanding rejections

An Office Action (OA) is the examiner’s written communication raising objections or rejections. Most OAs contain multiple rejections applied to multiple claims — a single application might see rejections under § 101 (eligibility), § 102 (novelty), and § 103 (obviousness) simultaneously.

§ 101

Eligibility

The claims cover patent-ineligible subject matter — abstract ideas, laws of nature, or natural phenomena. Common in software and biotech. Requires re-drafting claims to recite a specific technical improvement rather than a general concept.

§ 102

Anticipation

A single prior art reference discloses every element of at least one claim. The examiner must map every claim element to one document. Overcome by distinguishing facts (the reference does not actually disclose element X) or by amending to add a distinguishing limitation.

§ 103

Obviousness

Two or more prior art references, combined in an obvious way, cover all claim elements. The most common rejection. Overcome by arguing the references teach away from the combination, that combining them would require undue experimentation, or secondary considerations (commercial success, long-felt need, failure of others).

§ 112

Specification

The claims are indefinite, not enabled, or lack written description support. Common when claims use vague terms like 'about,' 'substantially,' or functional claim language without adequate support in the specification.

Full guide: Office Actions — What to Do When the USPTO Rejects Your Application →

After a final rejection

Three paths forward

RCE

Request for Continued Examination

Cost: ~$1,320 large / $660 small

Reopens prosecution; next OA is non-final

Use when:

You have a genuine amendment that works but needs more rounds. New prior art was cited in the final OA and you need to respond properly.

Risk:

RCEs toll the patent term and delay grant. Too many RCEs can signal a weak case.

Appeal

PTAB Ex Parte Appeal

Cost: $880 Notice + $880 brief filing fee

2–4 years to PTAB decision

Use when:

You believe the examiner is legally wrong and the rejection would not withstand review. PTAB reverses examiners ~45–50% of the time.

Risk:

Slow and expensive if you lose. Prosecution stays frozen during appeal — no new evidence.

After-Final Amendment

37 C.F.R. § 1.116

Cost: No filing fee (attorney fees for drafting)

Examiner has discretion to enter or refuse

Use when:

A narrow amendment clearly puts the claims in condition for allowance. The examiner may accept it without requiring RCE.

Risk:

Examiner can refuse entry if the amendment raises new issues. No guarantee of entry.

Critical concept

Prosecution history estoppel

Every word you write during prosecution becomes part of the permanent public record — and courts use it to limit your patent’s scope in litigation. This is prosecution history estoppel (also called file wrapper estoppel).

When you amend a claim to add a limitation in order to overcome a prior art rejection, you surrender the subject matter between the original and amended claim. In future litigation, you generally cannot argue that a product lacking that limitation still infringes under the doctrine of equivalents. The 2002 Supreme Court decision in Festo Corp. v. Shoketsu Kinzoku Kogyo Kabushiki Co. established that any narrowing amendment creates a presumption of estoppel for the surrendered subject matter.

Prosecution record matters because:

Courts construe claim terms using the prosecution history
Narrowing amendments to overcome prior art create estoppel
Arguments distinguishing prior art also define what is surrendered
Examiner interviews are summarized on the record

Drafting strategy implications:

Write arguments narrowly — don't over-distinguish when a narrow point wins
Reserve broader arguments for appeal rather than amending unnecessarily
File continuation applications to pursue broader claims before the parent issues
Conduct examiner interviews early — interviews often resolve OAs without amendments

Continuation strategy

Filing continuations during prosecution

A continuation application claims the same disclosure as the parent but with different (often broader or differently-scoped) claims. Continuations must be filed while the parent application is still pending — once the parent issues as a granted patent or is abandoned, the window closes.

Major patent filers like Apple, Qualcomm, and IBM routinely file continuations during prosecution to pursue multiple claim sets from one invention. A parent application might issue with narrow device claims while a continuation pursues broader method claims and a divisional covers a separately-invented aspect.

Types of continuation

Continuation (CON)

Same disclosure, new claims. All claims must be supported by the original specification. Priority date of the parent.

Continuation-in-Part (CIP)

Adds new matter to the specification. The new matter has a later priority date — creating two priority dates within one application.

Divisional (DIV)

Filed in response to a restriction requirement — the examiner splits one application into two because claims cover separate inventions. Claims are restricted to the non-elected invention.

Full guide: Continuation Patents Explained →

FAQ

Common prosecution questions

How long does patent prosecution take?

Average USPTO pendency (time from filing to grant or abandonment) is approximately 22–25 months for utility patents. Technology Art Unit matters significantly: electrical engineering and computer-implemented inventions often take 30–36+ months; mechanical applications can take 18–24 months. Track One prioritized examination costs $4,140 (large entity) and typically results in a first action within 3 months and final disposition within 12 months. Complex applications with multiple OA rounds or PTAB appeals can take 5–7+ years.

What is a non-final vs final Office Action?

A non-final Office Action is the USPTO's first substantive action rejecting claims. It opens the prosecution — you have 3 months (extendable to 6 months with fees) to respond. Your response can argue without amending, amend claims, or both. A final Office Action follows if the examiner maintains rejections after your response. After a final OA, your options are: (1) amend in a way the examiner finds allowable, (2) file a Request for Continued Examination (RCE) to reopen prosecution, (3) appeal to the Patent Trial and Appeal Board (PTAB), or (4) abandon. The term 'final' is somewhat misleading — prosecution can continue via RCE.

What is prosecution history estoppel?

Prosecution history estoppel (also called file wrapper estoppel) is the legal doctrine that narrowing amendments made to overcome prior art rejections during prosecution limit the scope of the doctrine of equivalents. If you amend a claim to add a limitation to distinguish a prior art reference, you generally cannot later argue in litigation that a product lacking that limitation still infringes under the doctrine of equivalents. The Festo Corp. v. Shoketsu Kinzoku Kogyo Kabushiki Co. (2002) Supreme Court case established that any narrowing amendment creates a presumption of estoppel for the surrendered subject matter.

What is an RCE and when should you file one?

A Request for Continued Examination (RCE) is filed under 37 C.F.R. § 1.114 after a final Office Action or after allowance to reopen prosecution. Filing an RCE pays the USPTO $1,320 (large entity) or $660 (small entity) and resets prosecution — the next OA will again be non-final. File an RCE when: (1) you have a genuine amendment that distinguishes the prior art but needs more prosecution, (2) after a final OA where new prior art was cited, (3) new claims need to be added after prosecution closes. RCEs toll the patent term — each delays the 20-year clock while costing time. Consider a continuation instead if you are opening a new line of claims.

Can you appeal a patent rejection?

Yes. After a final rejection (or an examiner's answer to an already-filed appeal), you can appeal to the Patent Trial and Appeal Board (PTAB) under 35 U.S.C. § 134. The appeal process involves: filing a Notice of Appeal ($880 large entity), filing an Appeal Brief (presenting your arguments), waiting for an Examiner's Answer, optionally filing a Reply Brief, and then a PTAB panel decision — typically 2–4 years from the Notice of Appeal. If PTAB affirms, you can petition the US Court of Appeals for the Federal Circuit. PTAB reverses the examiner about 45–50% of the time in ex parte appeals.